Clinical trial for Lung Cancer
Official title The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III
ClinicalTrials.gov ID: NCT04871412
What this study is testing
- What it's testing
- The study wants to see if adding a personalized integrative care plan can lower surgery complications, improve quality of life, and help patients live longer after cancer surgery.
- Who it's for
- Adults who are scheduled for curative surgery for lung, gastric, or esophageal cancer.
- What's involved
- Participants will receive a tailored integrative care program that may include nutrition, exercise, stress‑management, and other complementary therapies, along with regular visits and health checks during and after surgery.
- Time commitment
- The program lasts from before surgery through several months after, with multiple clinic visits and follow‑up assessments.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults eligible for complete resection of lung, gastric or esophageal cancer
You likely can't join if
- Small cell, carcinoid, or gastrointestinal stromal (GIST) tumours
- Any wedge resections of lung cancer
- History of cancer with active treatment in the last 3 years (not including superficial bladder cancer or non-melanoma skin cancer)
- Patients currently receiving care guided by an ND or who have previously seen an ND in the last 3 months
- Pregnant or breastfeeding women\
- Any reason which, in the opinion of the Principal Investigator (or delegate), would prevent the subject from participating in the study
See the full eligibility criteria
- Adults eligible for complete resection of lung, gastric or esophageal cancer
- Small cell, carcinoid, or gastrointestinal stromal (GIST) tumours
- Any wedge resections of lung cancer
- History of cancer with active treatment in the last 3 years (not including superficial bladder cancer or non-melanoma skin cancer)
- Patients currently receiving care guided by an ND or who have previously seen an ND in the last 3 months
- Pregnant or breastfeeding women\
- Any reason which, in the opinion of the Principal Investigator (or delegate), would prevent the subject from participating in the study
- Use of an investigational drug or participation in an investigational study within 30 days prior to starting the study
The study team makes the final eligibility decision.
Where it is enrolling
- Ottawa, Ontario, Canada
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Ottawa, Ontario, Canada; Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.